News Conference News CRT 2025 SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years L.A. McKeown March 10, 2025
News Conference News BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years Caitlin E. Cox March 02, 2022
News Conference News CRT 2021 BIOSTEMI at 2 Years: Orsiro Continues to Lower TLF in STEMI Patients Caitlin E. Cox March 16, 2021
News Conference News CRT 2021 Low Mortality and Stroke Rates With BASILICA Pre-TAVI, Registry Shows Michael O'Riordan March 09, 2021
News Conference News CRT 2020 Long-term Survival Data Promising for Carillon Repair Device in Functional MR L.A. McKeown March 03, 2020
News Conference News CRT 2020 Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation Michael O'Riordan February 26, 2020
News Conference News CRT 2020 BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis L.A. McKeown February 25, 2020
News Conference News CRT 2019 SAFE-DCB Demonstrates Consistent Efficacy at 1 Year in Real-world Femoropopliteal Disease Patients Yael L. Maxwell March 14, 2019
News Conference News CRT 2019 CABG vs PCI in Left Main Disease: The Debate Continues Yael L. Maxwell March 12, 2019
News Conference News CRT 2019 New ALERTS Data Support Use of Implantable Cardiac Monitor in High-Risk ACS Patients—With Caveats Yael L. Maxwell March 03, 2019
News Conference News CRT 2018 Early Results for Dock-Plus-Valve Approach Promising in Transcatheter Mitral Valve Replacement Shelley Wood March 07, 2018
News Conference News CRT 2017 Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation Michael O'Riordan February 22, 2017
News Conference News CRT 2016 Early Results for Transcatheter Mitral Valve Replacement Reveal Complications and Challenges for the Long Road Ahead Shelley Wood February 21, 2016